Daxor Announces Tahlequah City Hospital of Tahlequah, OK Acquires BVA-100 Blood Volume Analyzer

NEW YORK, NY--(Marketwire - January 30, 2009) - Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from Tahlequah City Hospital of Tahlequah, Oklahoma.

Tahlequah City Hospital (TCH) is a 100-bed rural hospital with a strategic plan designed to turn TCH into a regional healthcare center. By recruiting top physicians in their respective field and acquiring state-of-the-art technology, TCH has already implemented a cardiovascular open-heart surgery program and a comprehensive nephrology program including dialysis services.

Dr. James Madison, TCH's Director of Nephrology, noted that, "Tahlequah's patient population is over-represented in the area of kidney disease. With the high incidence of diabetes and hypertension we are using sophisticated techniques to support the needs of our open-heart and nephrology patients. I've seen the benefit of treating patients based upon an intravascular blood volume measurement, which is why the inclusion of this service is an important adjunct to our program and demonstrates TCH's commitment to providing the best of care."

Dr. Joseph Feldschuh, Daxor's C.E.O. and a practicing cardiologist, stated that, "The use of the BVA-100 by Tahlequah City Hospital is a critical step forward to improving the care of renal dialysis patients, who undergo major changes in blood volume during their course of dialysis. It is expected that utilization of the BVA-100 will enable physicians to provide a more precise dialysis treatment."

Daxor's Blood Volume Analyzer BVA-100 will be located within TCH's Nuclear Medicine Department and will be utilized to diagnose a variety of patient blood volume derangements.

Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.

Contact Information: Contact Information: Stephen Feldschuh Chief Operating Officer 212-330-8515 stephen@daxor.com or Diane Meegan Investor Relations 212-330-8512 dmeegan@daxor.com